Perspective review uncovers limitations in conventional codon optimization for living therapeutics, suggesting AI-guided sequence design improves protein expression control.
Engineering biological systems with intended sense-and-response functions requires precise control over the expression of their genetic elements.1,2 Achieving robust and durable protein production, however, remains a central challenge in living therapeutics. In addition to regulation through promoters, enhancers, and untranslated regions, coding sequences provide another layer of control over translation efficiency, transcript stability, and protein output. Conventional codon-optimization strategies typically rely on predefined metrics, such as codon usage, GC content, and predicted RNA structure,3 but may not fully capture the context-dependent effects of synonymous sequence variation.
No takes yet. Share an insight, caveat, or question.
Clement T. Y. Chan (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: